BM-531

N/A

Report date: 2023/06/16 09:25:28
NME

Base Information

Drug NameBM-531
Drug Alias NameBM-531
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsThromboxane A2 receptor antagonists
TargetsThromboxane A2 synthaseThromboxane A2 receptor
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Namur Rucb
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Namur Rucb
Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A